At a glance
- Originator Tsumura
- Class Antiretrovirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 27 Jul 2001 Discontinued - Preclinical for HIV-1 infections in Japan (unspecified route)
- 20 May 1996 New profile
- 20 May 1996 Preclinical development for HIV-1 infections in Japan (Unknown route)